[
  {
    "ts": null,
    "headline": "Does Zimmer Biomet’s Raised Guidance and Lower Tariff Headwinds Strengthen the Bull Case for ZBH?",
    "summary": "Zimmer Biomet reported better-than-expected Q2 2025 results, with revenues of US$2.08 billion and adjusted EPS of US$2.07, leading management to raise full-year forecasted adjusted EPS to US$8.10–US$8.30 and reduce its anticipated tariff headwinds to about US$40 million. Industry analysts pointed to the company's reduced tariff impact and upwardly revised guidance as factors that set Zimmer Biomet apart among peers in a strong quarter for surgical equipment and consumables. We'll examine how...",
    "url": "https://finnhub.io/api/news?id=37fe211bff5cf3d66c211902a0b5dea2c493a0e7350fd2d8273ad30aeeed68e2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758372595,
      "headline": "Does Zimmer Biomet’s Raised Guidance and Lower Tariff Headwinds Strengthen the Bull Case for ZBH?",
      "id": 136828325,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Zimmer Biomet reported better-than-expected Q2 2025 results, with revenues of US$2.08 billion and adjusted EPS of US$2.07, leading management to raise full-year forecasted adjusted EPS to US$8.10–US$8.30 and reduce its anticipated tariff headwinds to about US$40 million. Industry analysts pointed to the company's reduced tariff impact and upwardly revised guidance as factors that set Zimmer Biomet apart among peers in a strong quarter for surgical equipment and consumables. We'll examine how...",
      "url": "https://finnhub.io/api/news?id=37fe211bff5cf3d66c211902a0b5dea2c493a0e7350fd2d8273ad30aeeed68e2"
    }
  }
]